ZNF324
gene geneOn this page
Also known as ZF5128ZNF324A
Summary
ZNF324 (zinc finger protein 324, HGNC:14096) is a protein-coding gene on chromosome 19q13.43, encoding Zinc finger protein 324A (O75467). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Acts upstream of or within with a positive effect on G1/S transition of mitotic cell cycle and cell population proliferation. Predicted to be active in nucleus.
Source: NCBI Gene 25799 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 133 total
- MANE Select transcript:
NM_014347
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:14096 |
| Approved symbol | ZNF324 |
| Name | zinc finger protein 324 |
| Location | 19q13.43 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | ZF5128, ZNF324A |
| Ensembl gene | ENSG00000083812 |
| Ensembl biotype | protein_coding |
| OMIM | 617477 |
| Entrez | 25799 |
Gene structure
Transcript identifiers
Ensembl transcripts: 11 — 11 protein_coding
ENST00000196482, ENST00000536459, ENST00000593925, ENST00000868897, ENST00000868898, ENST00000868899, ENST00000868900, ENST00000868901, ENST00000960633, ENST00000960634, ENST00000960635
RefSeq mRNA: 1 — MANE Select: NM_014347
NM_014347
CCDS: CCDS12981
Canonical transcript exons
ENST00000196482 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001005524 | 58467080 | 58467183 |
| ENSE00002249748 | 58470731 | 58475436 |
| ENSE00002437418 | 58469180 | 58469306 |
| ENSE00002502706 | 58469728 | 58469844 |
Expression profiles
Bgee: expression breadth ubiquitous, 140 present calls, max score 81.21.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 7.4990 / max 118.9985, expressed in 1762 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 177847 | 6.7648 | 1751 |
| 177848 | 0.7342 | 444 |
Top tissues by expression
140 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cortical plate | UBERON:0005343 | 81.21 | gold quality |
| sural nerve | UBERON:0015488 | 78.35 | gold quality |
| prefrontal cortex | UBERON:0000451 | 78.31 | gold quality |
| stromal cell of endometrium | CL:0002255 | 77.81 | gold quality |
| right lobe of liver | UBERON:0001114 | 77.46 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 77.37 | gold quality |
| frontal cortex | UBERON:0001870 | 77.00 | gold quality |
| granulocyte | CL:0000094 | 76.67 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 76.09 | gold quality |
| ventricular zone | UBERON:0003053 | 75.97 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 75.54 | gold quality |
| ganglionic eminence | UBERON:0004023 | 75.48 | gold quality |
| blood | UBERON:0000178 | 75.38 | gold quality |
| cerebellum | UBERON:0002037 | 75.26 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 75.22 | gold quality |
| cerebellar cortex | UBERON:0002129 | 75.18 | gold quality |
| right frontal lobe | UBERON:0002810 | 75.16 | gold quality |
| adenohypophysis | UBERON:0002196 | 75.10 | gold quality |
| cerebral cortex | UBERON:0000956 | 74.74 | gold quality |
| pituitary gland | UBERON:0000007 | 74.60 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 74.28 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 74.21 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 74.09 | gold quality |
| bone marrow | UBERON:0002371 | 74.08 | gold quality |
| urinary bladder | UBERON:0001255 | 74.01 | gold quality |
| liver | UBERON:0002107 | 73.85 | gold quality |
| left uterine tube | UBERON:0001303 | 73.71 | gold quality |
| mucosa of stomach | UBERON:0001199 | 73.70 | gold quality |
| esophagus mucosa | UBERON:0002469 | 73.68 | gold quality |
| skin of leg | UBERON:0001511 | 73.64 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.84 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA1977.1 | ZNF324 | More than 3 adjacent zinc fingers |
| MA1977.2 | ZNF324 | More than 3 adjacent zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:28273063
miRNA regulators (miRDB)
54 targeting ZNF324, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-9-5P | 100.00 | 72.28 | 2361 |
| HSA-MIR-3689D | 100.00 | 66.14 | 1181 |
| HSA-MIR-6851-5P | 100.00 | 65.63 | 1294 |
| HSA-MIR-5193 | 100.00 | 67.26 | 1744 |
| HSA-MIR-4682 | 100.00 | 68.89 | 1258 |
| HSA-MIR-12118 | 100.00 | 65.88 | 1270 |
| HSA-MIR-6891-5P | 99.98 | 66.53 | 1372 |
| HSA-MIR-3173-3P | 99.98 | 66.49 | 1217 |
| HSA-MIR-499A-5P | 99.98 | 70.79 | 1323 |
| HSA-MIR-4493 | 99.90 | 66.48 | 977 |
| HSA-MIR-7845-5P | 99.88 | 64.88 | 771 |
| HSA-MIR-6857-5P | 99.87 | 65.32 | 985 |
| HSA-MIR-4779 | 99.86 | 66.50 | 1583 |
| HSA-MIR-6842-5P | 99.80 | 67.54 | 1587 |
| HSA-MIR-7110-5P | 99.80 | 67.84 | 1712 |
| HSA-MIR-4428 | 99.73 | 66.41 | 1733 |
| HSA-MIR-6752-3P | 99.72 | 66.71 | 1587 |
| HSA-MIR-4524A-3P | 99.72 | 66.85 | 2406 |
| HSA-MIR-1283 | 99.69 | 72.42 | 3009 |
| HSA-MIR-6892-3P | 99.68 | 66.40 | 1178 |
| HSA-MIR-4527 | 99.66 | 67.43 | 714 |
| HSA-MIR-3202 | 99.66 | 67.70 | 2737 |
| HSA-MIR-6503-5P | 99.62 | 66.96 | 597 |
| HSA-MIR-1249-5P | 99.61 | 66.55 | 2049 |
| HSA-MIR-6752-5P | 99.59 | 67.32 | 1243 |
| HSA-MIR-6751-5P | 99.56 | 64.99 | 1145 |
| HSA-MIR-4753-5P | 99.54 | 68.51 | 1356 |
| HSA-MIR-642A-5P | 99.51 | 65.10 | 1152 |
| HSA-MIR-6803-5P | 99.19 | 63.90 | 1026 |
| HSA-MIR-361-5P | 98.95 | 70.16 | 1340 |
Literature-anchored findings (GeneRIF, showing 1)
- Biological functions of miRNA-203b-3p/ZNF324 in laryngeal carcinoma. (PMID:38279443)
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | 42sp43 | ENSDARG00000104170 |
| mus_musculus | Zfp324 | ENSMUSG00000004500 |
| rattus_norvegicus | Zfp324 | ENSRNOG00000027436 |
| drosophila_melanogaster | dwg | FBGN0000520 |
| drosophila_melanogaster | CG6654 | FBGN0038301 |
| caenorhabditis_elegans | WBGENE00003933 |
Paralogs (6): ZBTB47 (ENSG00000114853), GTF3A (ENSG00000122034), ZUP1 (ENSG00000153975), ZNF513 (ENSG00000163795), ZNF652 (ENSG00000198740), ZNF324B (ENSG00000249471)
Protein
Protein identifiers
Zinc finger protein 324A — O75467 (reviewed: O75467)
Alternative names: Zinc finger protein ZF5128
All UniProt accessions (2): O75467, M0R1C8
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation. May be involved in regulation of cell proliferation.
Subcellular location. Nucleus.
Tissue specificity. Expressed at high levels in the spleen, thymus, and PBMC, at low levels in the prostate, ovary, small intestine, colon (mucosal lining), placenta, lung, and pancreas, and very weakly expressed in the liver and kidney.
Induction. Induced at the early stage of T cell activation. Regulated at the transcriptional level during the cell cycle. Induced at a maximum level in the S phase.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (1): NP_055162* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352
UniProt features (14 total): zinc finger region 9, region of interest 2, chain 1, domain 1, short sequence motif 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O75467-F1 | 64.68 | 0.39 |
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
| R-HSA-9843940 | Regulation of endogenous retroelements by KRAB-ZFP proteins |
MSigDB gene sets: 71 (showing top):
GOBP_CELL_CYCLE_PHASE_TRANSITION, ROVERSI_GLIOMA_COPY_NUMBER_UP, GOBP_CELL_CYCLE_G1_S_PHASE_TRANSITION, MODULE_123, GOBP_MITOTIC_CELL_CYCLE, GOBP_CELL_CYCLE_PROCESS, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, MARTENS_TRETINOIN_RESPONSE_DN, CSR_EARLY_UP.V1_UP, ATM_DN.V1_UP, RELA_DN.V1_UP, REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION, PRC2_EZH2_UP.V1_UP, PRC2_SUZ12_UP.V1_UP, PDGF_ERK_DN.V1_DN
GO Biological Process (4): G1/S transition of mitotic cell cycle (GO:0000082), regulation of transcription by RNA polymerase II (GO:0006357), cell population proliferation (GO:0008283), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (5): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
| Regulation of endogenous retroelements | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| mitotic cell cycle | 1 |
| mitotic cell cycle phase transition | 1 |
| cell cycle G1/S phase transition | 1 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| cellular process | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
744 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF324 | TRIM28 | Q13263 | 528 |
| ZNF324 | ZNF382 | Q96SR6 | 400 |
| ZNF324 | ZNF224 | P17033 | 399 |
| ZNF324 | GSPT1 | P15170 | 367 |
| ZNF324 | GJD3 | Q8N144 | 335 |
| ZNF324 | CHERP | Q8IWX8 | 324 |
| ZNF324 | ARHGAP25 | P42331 | 306 |
| ZNF324 | UBL3 | O95164 | 298 |
| ZNF324 | PHF3 | Q92576 | 295 |
| ZNF324 | ERH | P70659 | 290 |
| ZNF324 | RNF26 | Q9BY78 | 271 |
| ZNF324 | RAP2C | Q9Y3L5 | 269 |
| ZNF324 | NFRKB | Q6P4R8 | 256 |
| ZNF324 | CLIC3 | O95833 | 249 |
| ZNF324 | MGST3 | O14880 | 244 |
IntAct
58 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF169 | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF324B | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF707 | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| VWCE | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| CACNG5 | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| PRG3 | ZNF324 | psi-mi:“MI:0914”(association) | 0.530 |
| RPF1 | ZNF324 | psi-mi:“MI:0914”(association) | 0.530 |
| TRIM28 | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| FBL | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF764 | SH3PXD2B | psi-mi:“MI:0914”(association) | 0.530 |
| TRIM28 | ZNF320 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF324B | ZNF324 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF460 | ZNF324 | psi-mi:“MI:0914”(association) | 0.530 |
| NOTCH2 | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| Trim28 | FTH1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| ZNF324 | RPL4 | psi-mi:“MI:0915”(physical association) | 0.400 |
| FBL | GXYLT2 | psi-mi:“MI:0914”(association) | 0.350 |
| NXF2B | MEIOC | psi-mi:“MI:0914”(association) | 0.350 |
| RFPL4B | KRBA1 | psi-mi:“MI:0914”(association) | 0.350 |
| EFEMP1 | ZNF316 | psi-mi:“MI:0914”(association) | 0.350 |
| PSME3 | ZNF891 | psi-mi:“MI:0914”(association) | 0.350 |
| SKAP1 | MYO9A | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (69): ZNF324 (Affinity Capture-RNA), ZNF324 (Affinity Capture-MS), ZNF324 (Affinity Capture-MS), ZNF324 (Affinity Capture-MS), ZNF324 (Affinity Capture-MS), ZNF324 (Affinity Capture-MS), ZNF324 (Affinity Capture-MS), ZNF324 (Affinity Capture-MS), ZNF324 (Affinity Capture-MS), ZNF324 (Affinity Capture-MS), ZNF324 (Affinity Capture-MS), ZNF324 (Affinity Capture-MS), ZNF324 (Affinity Capture-MS), ZNF324 (Affinity Capture-MS), ZNF324 (Affinity Capture-MS)
ESM2 similar proteins: A3KN32, A6NM28, A8K8V0, E9PYI1, O75467, O95201, P10072, P10075, P10078, P10754, P28698, P30373, P52736, Q0VCC5, Q14929, Q16587, Q17QR7, Q29RZ4, Q3KNW1, Q3TDE8, Q3US17, Q58DK7, Q5RJR4, Q5T619, Q5TEC3, Q5U4E2, Q62396, Q68H95, Q6AW86, Q6PGE4, Q6ZMY9, Q7Z398, Q7Z7K2, Q8BI73, Q8BIF9, Q8BIQ3, Q8BKK5, Q8JZL0, Q8N393, Q8R0T2
Diamond homologs: A0JPL0, A2A761, A3KN32, A3KN36, A6NFI3, A6NM28, A6QLU5, A6QPT6, A7MBI1, A8MTY0, B2RXC5, B4DU55, E9PYI1, O14978, O60765, O75467, O75820, O95780, P0C7X2, P0DKX0, P0DPD5, P10072, P15622, P16374, P17014, P17023, P17032, P17098, P51523, P51786, P52738, P52742, Q02975, Q06732, Q08DG8, Q08ER8, Q0VCB0, Q14590, Q14929, Q29RZ4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
133 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 114 |
| Likely benign | 8 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
973 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:58467181:A:T | donor_gain | 1.0000 |
| 19:58469176:TTA:T | acceptor_loss | 1.0000 |
| 19:58469177:TA:T | acceptor_loss | 1.0000 |
| 19:58469178:A:AG | acceptor_gain | 1.0000 |
| 19:58469178:AG:A | acceptor_gain | 1.0000 |
| 19:58469178:AGGA:A | acceptor_loss | 1.0000 |
| 19:58469179:G:GT | acceptor_gain | 1.0000 |
| 19:58469179:GG:G | acceptor_gain | 1.0000 |
| 19:58469179:GGACC:G | acceptor_gain | 1.0000 |
| 19:58469302:GCTGG:G | donor_gain | 1.0000 |
| 19:58469304:TGGG:T | donor_loss | 1.0000 |
| 19:58469305:GG:G | donor_gain | 1.0000 |
| 19:58469306:GG:G | donor_gain | 1.0000 |
| 19:58469306:GGT:G | donor_loss | 1.0000 |
| 19:58469307:G:C | donor_loss | 1.0000 |
| 19:58469307:G:GG | donor_gain | 1.0000 |
| 19:58469308:T:G | donor_loss | 1.0000 |
| 19:58469723:CACAG:C | acceptor_loss | 1.0000 |
| 19:58469724:ACAG:A | acceptor_gain | 1.0000 |
| 19:58469726:A:AG | acceptor_gain | 1.0000 |
| 19:58469726:A:AT | acceptor_loss | 1.0000 |
| 19:58469726:AG:A | acceptor_gain | 1.0000 |
| 19:58469727:G:GA | acceptor_gain | 1.0000 |
| 19:58469727:GG:G | acceptor_gain | 1.0000 |
| 19:58469727:GGA:G | acceptor_gain | 1.0000 |
| 19:58469727:GGAC:G | acceptor_gain | 1.0000 |
| 19:58469727:GGACT:G | acceptor_gain | 1.0000 |
| 19:58469831:G:GT | donor_gain | 1.0000 |
| 19:58469842:CTGG:C | donor_loss | 1.0000 |
| 19:58469845:G:GG | donor_gain | 1.0000 |
AlphaMissense
3579 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:58471372:T:C | F294L | 1.000 |
| 19:58471374:C:A | F294L | 1.000 |
| 19:58471374:C:G | F294L | 1.000 |
| 19:58471288:T:C | F266L | 0.999 |
| 19:58471290:C:A | F266L | 0.999 |
| 19:58471290:C:G | F266L | 0.999 |
| 19:58471456:T:C | F322L | 0.999 |
| 19:58471458:C:A | F322L | 0.999 |
| 19:58471458:C:G | F322L | 0.999 |
| 19:58471540:T:C | F350L | 0.999 |
| 19:58471542:C:A | F350L | 0.999 |
| 19:58471542:C:G | F350L | 0.999 |
| 19:58471624:T:C | F378L | 0.999 |
| 19:58471626:C:A | F378L | 0.999 |
| 19:58471626:C:G | F378L | 0.999 |
| 19:58471708:T:C | F406L | 0.999 |
| 19:58471710:C:A | F406L | 0.999 |
| 19:58471710:C:G | F406L | 0.999 |
| 19:58471792:T:C | F434L | 0.999 |
| 19:58471794:T:A | F434L | 0.999 |
| 19:58471794:T:G | F434L | 0.999 |
| 19:58471876:T:C | F462L | 0.999 |
| 19:58471878:C:A | F462L | 0.999 |
| 19:58471878:C:G | F462L | 0.999 |
| 19:58471960:T:C | F490L | 0.999 |
| 19:58471962:C:A | F490L | 0.999 |
| 19:58471962:C:G | F490L | 0.999 |
| 19:58471307:T:C | L272P | 0.998 |
| 19:58471317:C:A | H275Q | 0.998 |
| 19:58471317:C:G | H275Q | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1000430399 (19:58475937 G>A,C), RS1000441917 (19:58467921 C>T), RS1000787520 (19:58472452 A>G), RS1000955127 (19:58472706 A>T), RS1001156533 (19:58468776 C>T), RS1001498615 (19:58467374 C>A,G,T), RS1001551015 (19:58467533 C>G,T), RS1001678933 (19:58468197 G>A), RS1001897208 (19:58475613 T>C), RS1001950987 (19:58475784 G>A,C), RS1002062748 (19:58471829 T>G), RS1002451723 (19:58472501 G>T), RS1002603678 (19:58473941 C>T), RS1003001846 (19:58470766 G>A,C), RS1003119416 (19:58470595 C>A,T)
Disease associations
OMIM: gene MIM:617477 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
27 total (human), top 27 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Aflatoxin B1 | increases expression, increases methylation | 2 |
| aristolochic acid I | increases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| bisphenol A | affects cotreatment, decreases expression | 1 |
| trichostatin A | affects expression | 1 |
| ferrous chloride | decreases expression | 1 |
| cupric oxide | increases expression | 1 |
| beta-methylcholine | affects expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| abrine | increases expression | 1 |
| 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid | decreases expression | 1 |
| Sunitinib | increases expression | 1 |
| Arsenic | affects methylation | 1 |
| Dexamethasone | affects cotreatment, decreases expression | 1 |
| Diazinon | increases methylation | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Indomethacin | affects cotreatment, decreases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Selenium | affects cotreatment, increases expression | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Urethane | increases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Vitamin E | affects cotreatment, increases expression | 1 |
| 1-Methyl-3-isobutylxanthine | affects cotreatment, decreases expression | 1 |
| Asbestos, Crocidolite | decreases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_HD20 | HEK293 eGFP-ZNF324 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.